未登录

P

Patrick Grierson

washington university

H指数:18

被引数:1,287

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Adaptive Salvage Stereotactic Radiation for Locoregional Recurrence of Pancreatic Adenocarcinoma After Surgery

术后胰腺腺癌局部区域复发后的自适应挽救性立体定向放射治疗

Practical Radiation Oncology

IF3.5

2026-04-300

PRE

Gastric Cancer, Version 2.2025

《胃癌》，版本2.2025

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2025-05-010

PRE

Ajani, Jaffer A.; D'Amico, Thomas A.; Bentrem, David J.; Corvera, Carlos U.; Das, Prajnan; Enzinger, Peter C.; Enzler, Thomas; Gerdes, Hans; Gibson, Michael K.; Grierson, Patrick; Gupta, Garima; Hofstetter, Wayne L.; Ilson, David H.; Jalal, Shadia; Kim, Sunnie; Kleinberg, Lawrence R.; Klempner, Samuel; Lacy, Jill; Lee, Byrne; Licciardi, Frank; Lloyd, Shane; Ly, Quan P.; Matsukuma, Karen; McNamara, Michael; Merkow, Ryan P.; Miller, Aaron M.; Mukherjee, Sarbajit; Mulcahy, Mary F.; Perry, Kyle A.; Pimiento, Jose M.; Reddi, Deepti M.; Reznik, Scott; Roses, Robert E.; Strong, Vivian E.; Su, Stacey; Uboha, Nataliya; Wainberg, Zev A.; Willett, Christopher G.; Woo, Yanghee; Yoon, Harry H.; McMillian, Nicole R.; Stein, MaryElizabeth

The TRIM4 E3 ubiquitin ligase degrades TPL2 and is modulated by oncogenic KRAS

IF6.9

2024-09-010

OAAI

Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer

联合kras-mapk通路抑制剂和HER2-directed药物偶联物对胰腺癌有效

NATURE COMMUNICATIONS

IF15.7

2024-03-204

OAAI

TRIM4 is the E3 ubiquitin-ligase for TPL2/MAP3K8 and is modulated by oncogenic KRAS

CANCER RESEARCH

IF16.6

2023-04-040

PRE

TNF-MK2 signaling drives protective autophagy following MAPK pathway inhibition in pancreatic cancer

CANCER RESEARCH

IF16.6

2023-04-040

PRE

IRAK4 Signaling Drives Resistance to Checkpoint in Pancreatic Ductal Adenocarcinoma

GASTROENTEROLOGY

IF25.1

2022-06-0126

OA

The MK2/Hsp27 axis is a major survival mechanism for pancreatic ductal adenocarcinoma under genotoxic stress

SCIENCE TRANSLATIONAL MEDICINE

IF14.6

2021-12-0110

PRE

Stroma-targeting strategies in pancreatic cancer: Past lessons, challenges and prospects

WORLD JOURNAL OF GASTROENTEROLOGY

IF5.4

2021-05-1427

OAAI

Vorolanib (X-82), an oral anti-VEGFR/PDGFR/CSF1R tyrosine kinase inhibitor, with everolimus in solid tumors: results of a phase I study

INVESTIGATIONAL NEW DRUGS

IF2.7

2021-03-1822

PREAI

CC Chemokine Receptor 2-Targeting Copper Nanoparticles for Positron Emission Tomography-Guided Delivery of Gemcitabine for Pancreatic Ductal Adenocarcinoma

IF16

2021-01-0642

OA

Essential role of IRAK4/TPL2 signaling axis in MAPK activation by oncogenic RAS and genotoxic stress

CANCER RESEARCH

IF16.6

2020-08-150

PRE

TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2020-08-1022

OA

Ramucirumab and irinotecan in patients with previously treated gastroesophageal adenocarcinoma: Interim analysis of a phase II trial

ANNALS OF ONCOLOGY

IF65.4

2020-07-011

OAAI

IRAK4 mediates colitis-induced tumorigenesis and chemoresistance in colorectal cancer

IF6.1

2019-10-0327

OA

Concurrent HER or PI3K Inhibition Potentiates the Antitumor Effect of the ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models

MOLECULAR CANCER THERAPEUTICS

IF5.5

2018-10-0137

OAAI

Rapid Clinical and Radiographic Response With Combined Dabrafenib and Trametinib in Adults With BRAF-Mutated High-Grade Glioma

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2018-01-0255

OAAI

Distinct Clinical and Magnetic Resonance Features of Metastatic Hepatocellular Carcinoma Treated With Pembrolizumab: A Case Report of Late Response After Pseudoprogression

HEPATOLOGY COMMUNICATIONS

IF4.6

2017-12-1918

OAAI

The BLM helicase facilitates RNA polymerase I-mediated ribosomal RNA transcription

CANCER RESEARCH

IF16.6

2014-10-280

PRE

BLM helicase facilitates RNA polymerase I-mediated ribosomal RNA transcription

HUMAN MOLECULAR GENETICS

IF3.2

2011-11-2155

OAAI